共 98 条
[1]
Stupp R(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996
[2]
Mason WP(2022)Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: a seer-medicare retrospective study Neurooncol Pract 9 299-309
[3]
van den Bent MJ(2005)MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997-1003
[4]
Wu A(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro Oncol 23 1231-1251
[5]
Ugiliweneza B(2009)IDH1 and IDH2 Mutations in Gliomas N Engl J Med 360 765-773
[6]
Wang D(2015)IDH-mutation is a weak predictor of long-term survival in glioblastoma patients PLoS ONE 11 1566-1572
[7]
Hegi ME(2015)Ki67 is a promising molecular target in the diagnosis of cancer (Review) Mol Med Rep 15 2717-2722
[8]
Diserens A-C(1995)Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer Anticancer Res 10 641-200
[9]
Gorlia T(2014)Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas J Cancer Res Ther 76 193-420
[10]
Louis DN(2006)Role of MIB1 in predicting survival in patients with glioblastomas J Neurooncol 16 411-204